date:Jan 16, 2014
th of 7-9% and an EBIT margin before special items above 26%. We continue to implement our new Natures No. 1 strategy to take Chr. Hansen to the next level.
Chr. Hansen has a strong balance sheet and remains committed to distributing excess capital to shareholders. To support this, the Board of Directors has decided to initiate a share buy-back program of up to EUR 80 million. The program is planned to be executed during the period from 15 January 2014 to 22 August 2014.
Highlights Q1 2013/14